VRTX
VRTX
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
1
$6.31M
Total Volume
$6.31M
1 transactions
Net Activity
$6.31M
Net selling
Sentiment Rating
Moderate DistributionCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Kewalramani Reshma
CEO, Pres
$6.31M total
Quick Actions
VRTX has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. VRTX ranks #171 in insider activity out of 569 tracked companies in its industry.
Over the last 90 days, corporate insiders at VRTX (VRTX) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 1 were sales. The total volume of insider trading reached $6.31M.
The net insider activity for VRTX shows a net selling bias of $6.31M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Kewalramani Reshma (CEO, Pres), who traded 11.9K shares valued at $6.31M on Nov 6, 2026.
Has Vertex Stock Become A Different Bet?
Vertex Pharmaceuticals (VRTX) Stock May Be Undervalued After Its 187% Run
Vertex Pharmaceuticals Stock Price Forecast. Should You Buy VRTX?
Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.17% on Nov 19: Facts Behind the Movement
Why Vertex Stock Just Triggered A Sell Rule
Vertex Pharmaceuticals(VRTX.US) Officer Sells US$8.37 Million in Common Stock
FAQs About VRTX Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for VRTX.